ERFSF News and Press, Eurofins Scientific S.E. From 12/20/23

2023-12-20 18:57:37 ET Summary Ruane, Cunniff & Goldfarb's 13F portfolio value decreased by 5% to $6.02B in Q3 2023. The top three positions in the portfolio are Alphabet, Intercontinental Exchange, and UnitedHealth. The firm increased Elevance Health during the quarter. ...

2023-12-14 12:28:25 ET Summary We return to the Testing, Inspection, and Certification market following an introductory article earlier this year. In this article, we focus on SGS SA, the market leader in this space. We conclude that the company is a good fit for investors loo...

The Eurofins network of companies, the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services, announces the completion of the acquisition of Quasfar. Known...

The Eurofins network of companies, the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services, announces the completion of the acquisition of Labor 3. The a...

2023-10-24 12:10:30 ET Eurofins Scientific SE (ERFSF) Q3 2023 Earnings Conference Call October 24, 2023 9:00 AM ET Company Participants Gilles Martin - Chairman and Chief Executive Officer Conference Call Participants Suhasini Varanasi - Goldman Sachs All...

2023-10-24 08:39:58 ET More on Eurofins Scientific Eurofins Scientific: The Normalization Of COVID-Related Sales Presents An Opportunity Eurofins Scientific Still Plans To More Than Double Its FCF By 2027 Historical earnings data for Eurofins Scientific Divid...

2023-10-20 12:26:39 ET Summary Eurofins is among the largest laboratory networks in Europe, offering essential services to stable industries such as food and beverages, as well as clinical diagnostics. The company experienced a substantial boost of revenues and margins during the ...

2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...

Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada ...

Eurofins CDMO Alphora Inc. is pleased to announce the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America. The multiphase initiative aims to establish a facility at the 2070 Hadwen site within ...